Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Respiratory and mediastinal neoplasms malignant and unspecified
ADR ID BADD_A03804
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10038666
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02147Telmisartan0.000521%
BADD_D02154Tenofovir--
BADD_D02165Teriflunomide0.000241%
BADD_D02192Thalidomide0.000723%
BADD_D02236Tofacitinib0.014636%
BADD_D02237Tofacitinib citrate--
BADD_D02246Tolvaptan0.000523%
BADD_D02248Topotecan0.000392%
BADD_D02249Topotecan hydrochloride--
BADD_D02252Tositumomab--
BADD_D02257Trametinib0.000392%
BADD_D02259Trandolapril--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000741%
BADD_D02337Varenicline0.001363%
BADD_D02342Vedolizumab--
BADD_D02344Vemurafenib0.000112%
BADD_D02345Venetoclax0.000112%
BADD_D02363Vinorelbine0.000112%
BADD_D02364Vinorelbine tartrate--
BADD_D02365Vismodegib0.000526%
BADD_D02369Voriconazole0.023234%
BADD_D02375Water--
BADD_D02392Zoledronic acid0.014315%
BADD_D02407Upadacitinib0.001326%
BADD_D02412Octreotide0.000559%
BADD_D02432Glycopyrronium0.001891%
BADD_D02436Atorvastatin0.000005%
BADD_D02441Rasagiline0.003247%
BADD_D02443Tiotropium0.001638%
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages